论文部分内容阅读
目的观察支原体肺炎应用阿奇霉素与热毒宁注射液治疗的临床效果。方法选取医院收治的支原体肺炎患者116例作为研究对象,随机分为研究组和对照组,每组58例。2组均采取退热、止咳、化痰等对症治疗,对照组应用阿奇霉素注射液治疗,研究组在对照组基础上应用热毒宁注射液治疗。观察2组临床治疗效果,咳嗽、发热消失时间及不良反应发生情况。结果研究组总有效率为96.55%高于对照组的84.48%(P<0.05)。研究组咳嗽消失时间与发热消失时间均短于对照组(P<0.01)。2组药物不良反应发生率比较差异无统计学意义(P>0.05)。结论支原体肺炎应用阿奇霉素与热毒宁注射液治疗效果肯定,安全性高,适于推广。
Objective To observe the clinical effect of azithromycin and rekinen injection in mycoplasma pneumonia. Methods A total of 116 patients with mycoplasmal pneumonia admitted to the hospital were selected as study subjects and randomly divided into study group and control group with 58 cases in each group. Both groups took antipyretic, cough, phlegm and other symptomatic treatment, the control group treated with azithromycin injection, the study group in the control group based on the application of heat toxicity rather injection. The clinical curative effect, cough, fever disappear time and adverse reaction were observed in two groups. Results The total effective rate of the study group was 96.55% higher than that of the control group (84.48%, P <0.05). The study group cough disappear time and fever disappear time are shorter than the control group (P <0.01). There was no significant difference in the incidence of adverse drug reactions between the two groups (P> 0.05). Conclusion Mycoplasma pneumonia with azithromycin and Reveroline injection treatment effect is affirmed, high safety, suitable for promotion.